Arcturus Therapeutics is trading 5.99% up now at $8.05, outperforming the broader market as U.S. stocks advance and investors show greater risk appetite after inflation data reduced near-term rate-hike concerns.
- No fresh company-specific announcement dated August 13, 2026, was identified.
- The latest company news remains its August 6 second-quarter update, which included an adjusted loss beat and pipeline progress; available reporting does not directly link it to today’s move.